Jensen Huang has heard the warnings. He is not buying them. The Nvidia chief runs the world’s most valuable company on the back of the AI boom. So when he calls the darkest predictions about that boom “complete nonsense,” it is worth asking whether he …
Apple spent years insisting the Mac would never get a touchscreen. That is about to change. The company is planning an overhaul of its entire Mac line, and the most striking new model is a MacBook you can prod with a finger. The refresh spans this autu…
Thailand does not usually feature in the story of the AI boom. This year it does. Foreign firms applied to invest 1.37tn baht, about $40.6bn, in the first six months of 2026, the country’s Board of Investment said on Thursday. That is up 80% on a year …
Vinod Khosla likes to be early. His firm was the first outside investor in OpenAI, back when that was a strange thing to be. Now Khosla Ventures is raising money to do it again, at a scale it has never tried. The firm is in talks to gather as much as $…
Everyone has lost access to something. A phone, a password, a recovery code sent to a dead email. Google’s answer, announced on Thursday, is your face. The company is adding a selfie video as a way to sign in, it said in a blog post. Setting it up take…
Uber has trimmed its customer-service ranks and pointed at AI. The company cut 10% of jobs in its community operations team on Wednesday. It is part of a wider push to “simplify operations, strengthen in-person collaboration, and continue to embrace AI…
The gap between American and Chinese AI is closing fast. Chinese models narrowed the performance shortfall to a record-low 6% in June, down from 9% in May, according to Bloomberg Intelligence. The research arm said the shift raises real questions about…
The model that rattled Silicon Valley last week now has Washington’s attention. A senior White House official has accused China’s Moonshot AI of breaking US export controls to build Kimi K3. It reached restricted Nvidia chips, he said, and leaned on Am…
Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment. And even then, most possible candidates never reach the patient. For biologic medicines, therapies made from engineered proteins rather than synthetic chemistry (which are often used to…
Jeff Bezos has found a new place to advertise Amazon’s artificial intelligence, and it happens to be the screen where you were hoping to watch a film. Amazon’s executive chairman is pushing a redesign of Prime Video, known internally as Lighthouse, mea…